CR-3663 series (Rottapharm Madaus)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCR-3663 series (Rottapharm Madaus)
Drug Alias NameNMDA receptor antagonists (Rottapharm Madaus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm Madaus Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm Madaus Gmbh
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A